Your browser doesn't support javascript.
loading
Molecular brain (micro report) oxytocin ameliorates impaired social behavior in a mouse model of 3q29 deletion syndrome.
Takemoto, Tomoya; Baba, Masayuki; Yokoyama, Kazumasa; Kitagawa, Kohei; Nagayasu, Kazuki; Ago, Yukio; Seiriki, Kaoru; Hayata-Takano, Atsuko; Kasai, Atsushi; Mori, Daisuke; Ozaki, Norio; Takuma, Kazuhiro; Hashimoto, Ryota; Hashimoto, Hitoshi; Nakazawa, Takanobu.
Afiliação
  • Takemoto T; Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, 565-0871, Japan.
  • Baba M; Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, 565-0871, Japan.
  • Yokoyama K; Discovery Accelerator, Astellas Pharma Inc., Tsukuba-shi, Ibaraki, 305-8585, Japan.
  • Kitagawa K; Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, 565-0871, Japan.
  • Nagayasu K; Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, 565-0871, Japan.
  • Ago Y; Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto, 606-8501, Japan.
  • Seiriki K; Department of Cellular and Molecular Pharmacology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Minami-ku, Hiroshima, 734-8553, Japan.
  • Hayata-Takano A; Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, 565-0871, Japan.
  • Kasai A; Interdisciplinary Program for Biomedical Sciences, Institute for Transdisciplinary Graduate Degree Programs, Osaka University, Suita, Osaka, 565-0871, Japan.
  • Mori D; Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, 565-0871, Japan.
  • Ozaki N; United Graduate School of Child Development, Molecular Research Center for Children's Mental Development, Osaka University, Kanazawa University, Hamamatsu University School of Medicine, Chiba University and University of Fukui, Suita, Osaka, 565-0871, Japan.
  • Takuma K; Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, 565-0871, Japan.
  • Hashimoto R; Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Aichi, 466-8550, Japan.
  • Hashimoto H; Brain and Mind Research Center, Nagoya University, Nagoya, Aichi, 466-8550, Japan.
  • Nakazawa T; Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Aichi, 466-8550, Japan.
Mol Brain ; 15(1): 26, 2022 03 28.
Article em En | MEDLINE | ID: mdl-35346312
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Comportamento Social / Ocitocina / Deleção Cromossômica / Transtorno do Espectro Autista / Deficiência Intelectual Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Comportamento Social / Ocitocina / Deleção Cromossômica / Transtorno do Espectro Autista / Deficiência Intelectual Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article